Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Oguzhan Durmaz, Metin Demirkaya & Betül Sevinir. (2011) Recombinant Human Erythropoietin β: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients. Pediatric Hematology and Oncology 28:6, pages 461-468.
Read now
Read now
Funda Çorapcioglu, Görkem Aksu, Eviç Z. Basar, Atalay Demirel, Selim Öncel & Ajda Mutlu. (2008) RECOMBINANT HUMAN ERYTHROPOIETIN BETA THERAPY: An Effective Strategy to Reduce Transfusion Requirement in Children Receiving Anticancer Treatment. Pediatric Hematology and Oncology 25:6, pages 509-521.
Read now
Read now
Nabil Abdelrazik & Manal Fouda. (2007) Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: A randomized case-controlled study. Hematology 12:6, pages 533-541.
Read now
Read now
Kyriaki Mystakidou, Anna Potamianou & Eleni Tsilika. (2007) Erythropoietic growth factors for children with cancer: a systematic review of the literature. Current Medical Research and Opinion 23:11, pages 2841-2847.
Read now
Read now
Hugo Donato. (2005) Erythropoietin: an update on the therapeutic use in newborn infants and children. Expert Opinion on Pharmacotherapy 6:5, pages 723-734.
Read now
Read now
Articles from other publishers (8)
Anurag K. Agrawal & Jeffrey D. Hord. 2015. Supportive Care in Pediatric Oncology. Supportive Care in Pediatric Oncology
247
260
.
Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert & Julia Bohlius. (2012) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger & Andreas Engert. (2009) Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Caroline Hastings & James Feusner. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
635
661
.
V. Witt & A. Zoubek. (2007) Erythropoetin in der pädiatrischen Hämatologie und OnkologieErythropoietin in pediatric hematology and oncology. Monatsschrift Kinderheilkunde 155:12, pages 1150-1158.
Crossref
Crossref
Jeffrey Blumer, Stacey Berg, Peter C. Adamson, Thomas Loew, Greg Rossi & Caroline Hastings. (2006) Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy‐induced anemia. Pediatric Blood & Cancer 49:5, pages 687-693.
Crossref
Crossref
Bassem I. Razzouk, Jeffrey D. Hord, Marilyn Hockenberry, Pamela S. Hinds, James Feusner, Denise Williams & Wayne R. Rackoff. (2006) Double-Blind, Placebo-Controlled Study of Quality of Life, Hematologic End Points, and Safety of Weekly Epoetin Alfa in Children With Cancer Receiving Myelosuppressive Chemotherapy. Journal of Clinical Oncology 24:22, pages 3583-3589.
Crossref
Crossref
Julia Bohlius, Jayne Wilson, Jerome Seidenfeld, Margret Piper, Guido Schwarzer, Josie Sandercock, Sven Trelle, Olaf Weingart, Susan Bayliss, Susan Brunskill, Benjamin Djulbegovic, Charles Bennett, Simon Langensiepen, Chris Hyde & Andreas Engert. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.